| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/12/2005 | CA2544498A1 Method for maintaining low shear in a bioprocessing system |
| 05/12/2005 | CA2544365A1 Modified anti-cd52 antibody |
| 05/12/2005 | CA2544300A1 Dose-dependent promoter originating in humans |
| 05/12/2005 | CA2544272A1 Meg1 endosperm-specific promoters and genes |
| 05/12/2005 | CA2543999A1 Monkey npy y4 receptor and method of evaluating compound |
| 05/12/2005 | CA2543794A1 Novel multipotent stem cells and use thereof |
| 05/12/2005 | CA2543745A1 Methods of organ regeneration |
| 05/12/2005 | CA2543685A1 Neutrophil activation by immune response modifier compounds |
| 05/12/2005 | CA2543528A1 Placental stem cells and uses thereof |
| 05/12/2005 | CA2543522A1 Phosphodiesterase 9 inhibition as treatment for obesity-related conditions |
| 05/12/2005 | CA2543127A1 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods |
| 05/12/2005 | CA2542810A1 Methods, compositions and devices for inducing stasis in tissues and organs |
| 05/12/2005 | CA2542806A1 Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms |
| 05/12/2005 | CA2541856A1 Modified polypeptides with therapeutic activity and methods of use |
| 05/12/2005 | CA2536238A1 Humanization of antibodies |
| 05/11/2005 | EP1529845A2 Fusion glycoprotein from HCMV and HSV |
| 05/11/2005 | EP1529838A1 Neural precursor and stem cells |
| 05/11/2005 | EP1529543A1 Use of a hydrogel for culturing chondrocytes |
| 05/11/2005 | EP1529113A1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 05/11/2005 | EP1529111A2 Genetically modified non-human mammal cells, procedure for their production and use in toxicity tests |
| 05/11/2005 | EP1529109A2 Production of multimeric fusion proteins using a c4bp scaffold |
| 05/11/2005 | EP1529108A2 Albumin-fused ciliary neurotrophic factor |
| 05/11/2005 | EP1529064A2 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 05/11/2005 | EP1529058A2 A non-selective cation channel in neural cells and methods for treating brain swelling |
| 05/11/2005 | EP1529055A2 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |
| 05/11/2005 | EP1529054A2 Therapeutic protein and treatments |
| 05/11/2005 | EP1528915A2 Liposomal vaccine |
| 05/11/2005 | EP1487967A4 Chimeric pancreas |
| 05/11/2005 | EP1322756A4 MANIPULATION OF PLANT SENESCENCE USING AN i MYB /i GENE PROMOTER AND CYTOKININ BIOSYNTHESIS GENES |
| 05/11/2005 | EP1248802B9 Soluble ctla4 mutant molecules and uses thereof |
| 05/11/2005 | EP1088069B1 Angiostatin-binding protein |
| 05/11/2005 | EP1062364B1 Qualitative differential screening |
| 05/11/2005 | EP0993470B1 Antibodies and other binding molecules specific for hepatitis b viral antigens |
| 05/11/2005 | EP0944725B1 Phosphodiesterase 8 |
| 05/11/2005 | EP0839196B1 Human ctla-8 and uses of ctla-8-related proteins |
| 05/11/2005 | EP0730606B1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR |
| 05/11/2005 | EP0625200B1 Biosynthetic binding protein for cancer marker |
| 05/11/2005 | EP0575350B1 Methods for the ex-vivo replication and stable genetic transformation of human stem cells |
| 05/11/2005 | CN1615439A Genes encoding g-protein coupled receptors and methods of use therefor |
| 05/11/2005 | CN1615362A Gene promoters |
| 05/11/2005 | CN1615357A Process for the manufacture of human mononuclear phagocytic leukocytes |
| 05/11/2005 | CN1615356A Method and system for fusion and activation following nuclear transfer in reconstructed embryos |
| 05/11/2005 | CN1615162A Augmentation of organ function |
| 05/11/2005 | CN1615161A Creation of tissue engineered female reproductive organs |
| 05/11/2005 | CN1615150A Assay for the detection of factors that modulate the expression of INGAP |
| 05/11/2005 | CN1615143A Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors |
| 05/11/2005 | CN1614026A Method for improving crop economic characteristic by FCA gene RNA structural zone transgene |
| 05/11/2005 | CN1614024A Transgened-tobacco for degrading organic mercury pollution |
| 05/11/2005 | CN1614021A Phloem specific expressing promoter |
| 05/11/2005 | CN1614010A Vacuum pneumatic plant cell wall breaking process and apparatus |
| 05/11/2005 | CN1613367A Orange peel jam with breaking-wall cell and preparation |
| 05/11/2005 | CN1201013C Adenovirus vectors and method for reducing homologous recombination phnomena |
| 05/11/2005 | CN1201006C High-affinity interleukin-4 muteins |
| 05/11/2005 | CN1201005C Antigen binding fragments that specifically detect cancer cells, nucleotindes encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/11/2005 | CN1201004C HER-2/neu fusion proteins |
| 05/11/2005 | CN1201003C Adipocyte-specific protein homologs |
| 05/11/2005 | CN1201001C Process of cell reprogramming |
| 05/11/2005 | CN1200654C Method and device for preparing dental implant by immersion in mesenchymal cell culture |
| 05/10/2005 | US6891088 For increased yield/oil/modified starch (amylose) content |
| 05/10/2005 | US6891086 Plastid transformation of Brassica |
| 05/10/2005 | US6891082 Transgenic nonhuman animal whose genome contains a nucleic acid sequence comprising a truncated Activin Type II receptor gene and a muscle-specific promoter operably linked and integrated into genome of animal; increased muscle mass |
| 05/10/2005 | US6891028 Nucleic acids encoding transferrin receptor-like proteins |
| 05/10/2005 | US6891023 Antibodies and Fv fragment recognizing antigen IOR C2 |
| 05/10/2005 | US6890755 Recovery of fetal cells from maternal blood using chaotic advection |
| 05/10/2005 | US6890754 Glycosylated collagen and fibroblast lattice containing keratinocytes; model for skin regeneration |
| 05/10/2005 | US6890753 Culturing preferential lymphocytes; obtain lymphocytes, inoculate nutrint broth, propagate, recover cells |
| 05/10/2005 | US6890752 Synthases |
| 05/10/2005 | US6890751 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/10/2005 | US6890750 For measurement of activation/inhibition of pathways converging at transcriptional activators in cells |
| 05/10/2005 | US6890732 Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch |
| 05/10/2005 | US6890731 For drug screeing/therapy of diseases; bacteriophages |
| 05/10/2005 | US6890728 Recovering cell components from sample; obtain cells sample, lyse, centrifuge, withdraw fluid, detect cell components |
| 05/10/2005 | US6890724 Antibody for use in the treatment of barre-guillaum syndrome |
| 05/10/2005 | US6890717 For diagnostics/screening assays/hybridization probes/primers/therapy for osteoporosis/periodontal disease |
| 05/10/2005 | US6890552 Manufacturing therapeutic enclosures |
| 05/10/2005 | US6890534 Aiolos genes and polypeptides of the present invention are useful for studying, diagnosing and/or treating diseases associated with unwanted cell proliferation, e.g., leukemias or lymphomas |
| 05/10/2005 | US6890532 Postexposure prophylaxis therapy |
| 05/10/2005 | US6890528 Cells for the production of helper dependent adenoviral vectors |
| 05/06/2005 | WO2005040815A1 Method of detecting hepatitis c virus |
| 05/06/2005 | WO2005040420A1 Rapid determination and quantification of mycoplasma contamination using dna chip technology |
| 05/06/2005 | WO2005040398A2 Methods for preserving nucleated mammalian cells |
| 05/06/2005 | WO2005040379A2 RNA INTERFERENCE MEDIATED INHIBITION OF RAS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/06/2005 | WO2005040377A2 High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences |
| 05/06/2005 | WO2005040374A1 Method of selecting genomic dna fragment |
| 05/06/2005 | WO2005040367A1 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives |
| 05/06/2005 | WO2005040362A1 Method for differentiating mesenchymal stem cell into neural cell and pharmaceutical composition containing the neural cell for neurodegenerative disease |
| 05/06/2005 | WO2005040361A1 Method of simply preparing stem cell and feeder cell to be used therein |
| 05/06/2005 | WO2005040360A1 Blood products from mesenchymal stem cells |
| 05/06/2005 | WO2005040333A2 Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism |
| 05/06/2005 | WO2005040332A2 Method and bioreactor for the cultivation and stimulation of three-dimensional vital and mechanically-resistant cell transplants |
| 05/06/2005 | WO2005040188A1 Hepatocellular carcinoma specific promoter and uses thereof |
| 05/06/2005 | WO2005039662A2 Cartilage regeneration by generation of chondrons under high concentrations of magnesium |
| 05/06/2005 | WO2005039643A2 In vivo gene therapy of parkinson's disease |
| 05/06/2005 | WO2005039488A2 Use of cxcr4 protein expression on the surface of stem cells as a marker for tumor tropic potential |
| 05/06/2005 | WO2005039291A2 Methods, compositions and devices for inducing stasis in cells |
| 05/06/2005 | WO2005026335A3 Insulin-producing bone marrow derived cells and methods of generating and using same |
| 05/06/2005 | WO2005017116A3 Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use |
| 05/06/2005 | WO2005010146A3 Adenoviral e1a/e1b complementing cell line |
| 05/06/2005 | WO2005005467A3 Novel immune booster compound comprising an ef adenoviral sequence |
| 05/06/2005 | WO2005003168A3 Methods for the production and cytotoxicity evaluation of kir2dl nk-receptor antibodies |